Intra-articular therapy in osteoarthritis
Open accessThe DOI matches its Crossref record.
Abstract
The medical literature was reviewed from 1968–2002 using Medline and the key words “intra-articular” and “osteoarthritis” to determine the various intra-articular therapies used in the treatment of osteoarthritis. Corticosteroids and hyaluronic acid are the most frequently used intra-articular therapies in osteoarthritis. Other intra-articular substances such as orgotein, radiation synovectomy, dextrose prolotherapy, silicone, saline lavage, saline injection without lavage, analgesic agents, non-steroidal anti-inflammatory drugs, glucosamine, somatostatin, sodium pentosan polysulfate, chloroquine, mucopolysaccharide polysulfuric acid ester, lactic acid solution, and thiotepa cytostatica have been investigated as potentially therapeutic in the treatment of arthritic joints. Despite the lack of strong, convincing, and reproducible evidence that any of the intra-articular therapies significantly alters the progression of osteoarthritis, corticosteroids and hyaluronic acid are widely used in patients who have failed other therapeutic modalities for lack of efficacy or toxicity. As a practical approach for a knee with effusion, steroid injections should be considered while the presence of symptomatic “dry” knees may favour the hyaluronic acid approach. The virtual absence of serious side effects, coupled with the perceived benefits, make these approaches attractive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hyaluronic acid (hyaluronan): A review
Necas, J., Bartosikova, L., Brauner, P., & Kolar, J. (2008) · Veterinární medicína · doi:10.17221/1930-vetmed · Cited by 998
“The unique viscoelastic nature of HA along with its biocompatibility and non-immunogenicity has led to its use in a number of clinical applications, including the supplementation of joint fluid in arthritis (Neo et al., 1997; Barbucci et al., 2002; Uthman et al., 2003; Medina et al., 2006), as a surgical aid in eye su…”
BackgroundInfluentialIntraarticular corticosteroid for treatment of osteoarthritis of the knee
Bellamy, N., Campbell, J., Welch, V., Gee, T. L., Bourne, R., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005328.pub2 · Cited by 762
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
Brown, M., & Jones, S. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01180.x · Cited by 373
Corticosteroid injections for osteoarthritis of the knee: Meta-analysis
Arroll, B., & Goodyear-Smith, F. (2004) · BMJ · doi:10.1136/bmj.38039.573970.7c · Cited by 348
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
Hyaluronan and synovial joint: function, distribution and healing
Tamer, T. M. (2013) · Interdisciplinary Toxicology · doi:10.2478/intox-2013-0019 · Cited by 317
Larsen, C., Østergaard, J., Larsen, S. W., Jensen, H., Jacobsen, S., Lindegaard, C., & Andersen, P. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21346 · Cited by 301
Johnston, P. C., Lansang, M. C., Chatterjee, S., & Kennedy, L. (2015) · Endocrine · doi:10.1007/s12020-014-0409-5 · Cited by 58
Schulze, C., Schunck, M., Zdzieblik, D., & Oesser, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21060687 · Cited by 10
“In addition, ACI and HA injections can cause side effects such as synovitis, joint swelling, hemarthrosis, muscle pain, pseudogout, arthrofibrosis and hemorrhage [10,11].”
Background
Metadata
- Authors
- Uthman, I., Raynauld, J.-P., & Haraoui, B.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 79
- Issue
- 934
- Pages
- 449-453
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2099901505
- Cited by
- 156
- References
- 0
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.